These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10348718)
1. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin. Ritchie H; Robbie LA; Kinghorn S; Exley R; Booth NA Thromb Haemost; 1999 Jan; 81(1):96-103. PubMed ID: 10348718 [TBL] [Abstract][Full Text] [Related]
2. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Lijnen HR; Wagner EF; Collen D Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597 [TBL] [Abstract][Full Text] [Related]
5. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue. Kirchheimer JC; Binder BR; Remold HG J Immunol; 1990 Sep; 145(5):1518-22. PubMed ID: 1696600 [TBL] [Abstract][Full Text] [Related]
6. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors. Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
9. Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells. Ritchie H; Jamieson A; Booth NA Thromb Haemost; 1997 Jun; 77(6):1168-73. PubMed ID: 9241752 [TBL] [Abstract][Full Text] [Related]
10. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis. Robbie LA; Booth NA; Croll AM; Bennett B Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits. Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501 [TBL] [Abstract][Full Text] [Related]
12. Monocyte-macrophage release of IL-1 is inhibited by type-1 plasminogen activator inhibitors. Robson SC; Saunders R; Kirsch RE J Clin Lab Immunol; 1990 Oct; 33(2):83-90. PubMed ID: 1967070 [TBL] [Abstract][Full Text] [Related]
13. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality. Paloma MJ; Páramo JA; Rocha E Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240 [TBL] [Abstract][Full Text] [Related]
14. Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma. Semeraro N; Montemurro P; Giordano P; Santoro N; De Mattia D; Colucci M Thromb Haemost; 1994 Jul; 72(1):54-7. PubMed ID: 7974375 [TBL] [Abstract][Full Text] [Related]
15. The role of the finger domain of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in initiation and progression of thrombolysis. Stringer HA; van Swieten P; Horrevoets AJ; Smilde A; Pannekoek H Thromb Haemost; 1994 Dec; 72(6):900-5. PubMed ID: 7740461 [TBL] [Abstract][Full Text] [Related]
16. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor? Camani C; Gavin O; Kruithof EK Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388 [TBL] [Abstract][Full Text] [Related]
17. Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL. Ritchie H; Jamieson A; Booth NA Thromb Haemost; 1995 Dec; 74(6):1521-7. PubMed ID: 8772231 [TBL] [Abstract][Full Text] [Related]
18. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
19. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1. Diamond MP; Kruger M; Saed GM Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491 [TBL] [Abstract][Full Text] [Related]
20. Longistatin, a novel plasminogen activator from vector ticks, is resistant to plasminogen activator inhibitor-1. Anisuzzaman ; Khyrul Islam M; Abdul Alim M; Miyoshi T; Hatta T; Yamaji K; Matsumoto Y; Fujisaki K; Tsuji N Biochem Biophys Res Commun; 2011 Oct; 413(4):599-604. PubMed ID: 21925150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]